New report explores pandemic’s effect on funding

A new report ‘Contraceptive Commodity Funding During the COVID-19 pandemic’ developed under the RHSC’s Compass Initiative shares the results of a deep analysis seeking to identify changes in donor and domestic financing for contraceptives during the pandemic period. Commissioned by the RHSC and produced by Avenir Health, the report seeks to understand the various impacts of the COVID-19 pandemic on public funding for contraceptive commodities and examines the underlying drivers for these changes (COVID-19 and otherwise). This slide presentation provides an executive summary, and RHSC Director Martyn Smith reflects on the report’s lessons here.